CARMAT completes enrolment in the EFICAS clinical study and receives approval from French authorities for 21 additional Aeson® implants, while awaiting potential reimbursement of the device in France
news, press release
April 14th 2025
CARMAT receives FDA conditional approval to initiate the second cohort of the EFS study in the United States
